EP Patent

EP2923702A1 — Composition of cyclodextrin with budesonide derivatives for treatment and prevention of pulmonary inflammatory disease

Assigned to Universite de Liege · Expires 2015-09-30 · 11y expired

What this patent protects

A pharmaceutical composition for use in the therapeutic and/or prevention treatment of pulmonary inflammatory disease, comprising a cyclodextrin compound and a budesonide derivative of formula I

USPTO Abstract

A pharmaceutical composition for use in the therapeutic and/or prevention treatment of pulmonary inflammatory disease, comprising a cyclodextrin compound and a budesonide derivative of formula I

Drugs covered by this patent

Patent Metadata

Patent number
EP2923702A1
Jurisdiction
EP
Classification
—
Expires
2015-09-30
Drug substance claim
No
Drug product claim
No
Assignee
Universite de Liege
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.